Stockscreener 앱 받기
7.855
0.75%
-0.005
전일 마감가:
$7.86
열려 있는:
$7.85
하루 거래량:
68,821
Relative Volume:
0.16
시가총액:
$668.68M
수익:
$81.18M
순이익/손실:
$-80.94M
주가수익비율:
-6.6517
EPS:
-1.1809
순현금흐름:
$-55.15M
1주 성능:
-6.68%
1개월 성능:
+4.02%
6개월 성능:
+69.22%
1년 성능:
+146.09%
1일 변동 폭
$7.76
$7.905
1주일 범위
$7.53
$8.37
52주 변동 폭
$3.15
$8.98
Sophia Genetics Sa Stock (SOPH) Company Profile
Compare SOPH vs VEEV, BTSG, TEM, TXG, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
7.855 | 669.96M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
266.34 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
58.83 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
65.05 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
74.41 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.29 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat
Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com
SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat
Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research
SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - marketbeat.com
SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media
SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat
EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
SOPHiA Genetics Earnings Call Highlights Growth Push - TipRanks
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com
Sophia Genetics SA (SOPH) Chief Scientific Officer Zhenyu Xu Sel - GuruFocus
SOPHiA GENETICS (SOPH) Slips 1.57% as Shares Consolidate Between Key Support and ResistanceStock Surge Alerts - vinanet.vn
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat
SOPHiA GENETICS (SOPH) Slips 0.53% to $7.57 as Genomics AI Stock Consolidates Between Key LevelsSeasonality Effect - Vinanet
SOPHiA GENETICS (SOPH) Consolidates at $7.57: Genomics Stock Poised Between Support and ResistanceCorrective Wave - vinanet.vn
Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 52-Week HighTime to Buy? - MarketBeat
Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
Abhimanyu Verma Sells 5,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 20,000 Shares - MarketBeat
Sei Investments Co. Buys Shares of 357,888 SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $123,930.00 in Stock - MarketBeat
SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades - Stock Titan
Sophia Genetics CSO Zhenyu Xu disposes of USD 170,872 in common shares - Bitget
SOPHiA GENETICS Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat
Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease - Startupticker.ch
HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock - MarketBeat
BTIG raises Sophia Genetics stock price target on CDx deals By Investing.com - Investing.com South Africa
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - MarketBeat
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sophia Genetics Sa 주식 (SOPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HIBBS KATHY L | Director |
Sep 08 '26 |
Sale |
8.13 |
6,250 |
50,818 |
96,992 |
| Xu Zhenyu | Chief Scientific Officer |
Aug 27 '26 |
Sale |
8.91 |
10,000 |
89,096 |
556,887 |
0.26%
5.25%
자본화:
|
볼륨(24시간):